Novavax, Inc. (NVAX)
USD 6.22
(10.98%)
USD 6.22
(10.98%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -298.29 Million USD | 62.1% |
| 2022 | -787.1 Million USD | 25.82% |
| 2021 | -1.06 Billion USD | -358.64% |
| 2020 | -231.36 Million USD | -195.19% |
| 2019 | 243.05 Million USD | -2.4% |
| 2018 | 249.03 Million USD | 17.77% |
| 2017 | 211.45 Million USD | 22.95% |
| 2016 | 171.98 Million USD | 285.5% |
| 2015 | -92.71 Million USD | -195.86% |
| 2014 | -31.33 Million USD | 73.28% |
| 2013 | -117.28 Million USD | -624.26% |
| 2012 | -16.19 Million USD | -17.48% |
| 2011 | -13.78 Million USD | -79.92% |
| 2010 | -7.66 Million USD | 79.98% |
| 2009 | -38.27 Million USD | -849.65% |
| 2008 | -4.03 Million USD | -121.9% |
| 2007 | 18.39 Million USD | 14.79% |
| 2006 | 16.02 Million USD | 1276.8% |
| 2005 | -1.36 Million USD | -107.06% |
| 2004 | 19.28 Million USD | 32.73% |
| 2003 | 14.53 Million USD | -62.16% |
| 2002 | 38.39 Million USD | 168.67% |
| 2001 | 14.29 Million USD | 178.27% |
| 2000 | 5.13 Million USD | 956.0% |
| 1999 | -600 Thousand USD | 40.0% |
| 1998 | -1 Million USD | 73.68% |
| 1997 | -3.8 Million USD | -52.0% |
| 1996 | -2.5 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -261.7 Million USD | 12.26% |
| 2024 Q2 | -457.4 Million USD | -70.77% |
| 2023 Q1 | -425.89 Million USD | 45.89% |
| 2023 Q4 | -298.29 Million USD | 30.47% |
| 2023 Q3 | -428.99 Million USD | -39.75% |
| 2023 Q2 | -306.96 Million USD | 27.92% |
| 2023 FY | -298.29 Million USD | 62.1% |
| 2022 FY | -787.1 Million USD | 25.82% |
| 2022 Q3 | -842.48 Million USD | 9.13% |
| 2022 Q4 | -787.1 Million USD | 6.57% |
| 2022 Q1 | -1.13 Billion USD | -6.53% |
| 2022 Q2 | -927.15 Million USD | 17.98% |
| 2021 Q4 | -1.06 Billion USD | 29.72% |
| 2021 FY | -1.06 Billion USD | -358.64% |
| 2021 Q1 | -1.53 Billion USD | -563.57% |
| 2021 Q2 | -1.64 Billion USD | -7.12% |
| 2021 Q3 | -1.5 Billion USD | 8.19% |
| 2020 FY | -231.36 Million USD | -195.19% |
| 2020 Q3 | 106.46 Million USD | 203.29% |
| 2020 Q2 | -103.07 Million USD | -173.06% |
| 2020 Q1 | 141.08 Million USD | -41.95% |
| 2020 Q4 | -231.36 Million USD | -317.31% |
| 2019 Q1 | 225.32 Million USD | -9.52% |
| 2019 FY | 243.05 Million USD | -2.4% |
| 2019 Q4 | 243.05 Million USD | -2.89% |
| 2019 Q3 | 250.27 Million USD | 0.96% |
| 2019 Q2 | 247.9 Million USD | 10.02% |
| 2018 FY | 249.03 Million USD | 17.77% |
| 2018 Q1 | 204.71 Million USD | -3.19% |
| 2018 Q2 | 230 Million USD | 12.35% |
| 2018 Q3 | 262.33 Million USD | 14.06% |
| 2018 Q4 | 249.03 Million USD | -5.07% |
| 2017 Q1 | 220.84 Million USD | 28.41% |
| 2017 Q4 | 211.45 Million USD | -0.8% |
| 2017 Q3 | 213.16 Million USD | -11.65% |
| 2017 FY | 211.45 Million USD | 22.95% |
| 2017 Q2 | 241.25 Million USD | 9.24% |
| 2016 FY | 171.98 Million USD | 285.5% |
| 2016 Q4 | 171.98 Million USD | -12.29% |
| 2016 Q2 | 226.38 Million USD | 23.5% |
| 2016 Q1 | 183.29 Million USD | 297.7% |
| 2016 Q3 | 196.08 Million USD | -13.38% |
| 2015 FY | -92.71 Million USD | -195.86% |
| 2015 Q1 | -214.21 Million USD | -583.6% |
| 2015 Q4 | -92.71 Million USD | 32.62% |
| 2015 Q2 | -166.7 Million USD | 22.18% |
| 2015 Q3 | -137.6 Million USD | 17.45% |
| 2014 Q4 | -31.33 Million USD | 4.66% |
| 2014 FY | -31.33 Million USD | 73.28% |
| 2014 Q3 | -32.86 Million USD | 67.79% |
| 2014 Q2 | -102.04 Million USD | 5.43% |
| 2014 Q1 | -107.91 Million USD | 7.99% |
| 2013 Q3 | -119.9 Million USD | -142645.24% |
| 2013 FY | -117.28 Million USD | -624.26% |
| 2013 Q4 | -117.28 Million USD | 2.18% |
| 2013 Q2 | -84 Thousand USD | 98.81% |
| 2013 Q1 | -7.06 Million USD | 56.39% |
| 2012 Q4 | -16.19 Million USD | -70.84% |
| 2012 Q1 | -13.46 Million USD | 2.31% |
| 2012 FY | -16.19 Million USD | -17.48% |
| 2012 Q2 | -14.93 Million USD | -10.9% |
| 2012 Q3 | -9.47 Million USD | 36.53% |
| 2011 FY | -13.78 Million USD | -79.92% |
| 2011 Q1 | -7.97 Million USD | -4.14% |
| 2011 Q2 | -12.73 Million USD | -59.59% |
| 2011 Q3 | -13.97 Million USD | -9.79% |
| 2011 Q4 | -13.78 Million USD | 1.39% |
| 2010 Q2 | -9 Million USD | 36.2% |
| 2010 Q3 | -15.79 Million USD | -75.38% |
| 2010 Q4 | -7.66 Million USD | 51.5% |
| 2010 Q1 | -14.11 Million USD | 63.12% |
| 2010 FY | -7.66 Million USD | 79.98% |
| 2009 Q4 | -38.27 Million USD | -30.75% |
| 2009 FY | -38.27 Million USD | -849.65% |
| 2009 Q1 | 3.1 Million USD | 177.05% |
| 2009 Q3 | -29.27 Million USD | -49.83% |
| 2009 Q2 | -19.53 Million USD | -729.18% |
| 2008 FY | -4.03 Million USD | -121.9% |
| 2008 Q2 | -1.38 Million USD | -117.17% |
| 2008 Q1 | 8.07 Million USD | -56.14% |
| 2008 Q3 | -14.73 Million USD | -963.2% |
| 2008 Q4 | -4.03 Million USD | 72.65% |
| 2007 Q4 | 18.39 Million USD | 171.01% |
| 2007 Q3 | 6.78 Million USD | -55.0% |
| 2007 Q2 | 15.08 Million USD | -5.18% |
| 2007 FY | 18.39 Million USD | 14.79% |
| 2007 Q1 | 15.91 Million USD | -0.72% |
| 2006 Q3 | 1.43 Million USD | 102.59% |
| 2006 Q4 | 16.02 Million USD | 1013.83% |
| 2006 Q1 | -60.76 Million USD | -4361.45% |
| 2006 FY | 16.02 Million USD | 1276.8% |
| 2006 Q2 | -55.64 Million USD | 8.42% |
| 2005 FY | -1.36 Million USD | -107.06% |
| 2005 Q3 | 29.26 Million USD | -8.59% |
| 2005 Q4 | -1.36 Million USD | -104.65% |
| 2005 Q2 | 32.02 Million USD | 15.94% |
| 2005 Q1 | 27.61 Million USD | 43.18% |
| 2004 FY | 19.28 Million USD | 32.73% |
| 2004 Q2 | 25.8 Million USD | 29.39% |
| 2004 Q1 | 19.94 Million USD | 37.26% |
| 2004 Q3 | 8.9 Million USD | -65.51% |
| 2004 Q4 | 19.28 Million USD | 116.69% |
| 2003 Q3 | 35.47 Million USD | 11.05% |
| 2003 Q4 | 14.53 Million USD | -59.04% |
| 2003 Q1 | 27.28 Million USD | -28.95% |
| 2003 FY | 14.53 Million USD | -62.16% |
| 2003 Q2 | 31.94 Million USD | 17.09% |
| 2002 Q3 | 32.37 Million USD | 34.47% |
| 2002 Q4 | 38.39 Million USD | 18.63% |
| 2002 FY | 38.39 Million USD | 168.67% |
| 2002 Q1 | 19.11 Million USD | 33.75% |
| 2002 Q2 | 24.07 Million USD | 25.94% |
| 2001 FY | 14.29 Million USD | 178.27% |
| 2001 Q1 | 11.1 Million USD | 116.26% |
| 2001 Q3 | 6.7 Million USD | -21.71% |
| 2001 Q2 | 8.56 Million USD | -22.9% |
| 2001 Q4 | 14.29 Million USD | 113.19% |
| 2000 Q1 | -14.61 Million USD | -2336.5% |
| 2000 Q2 | -12.24 Million USD | 16.22% |
| 2000 Q3 | -10.05 Million USD | 17.87% |
| 2000 Q4 | 5.13 Million USD | 151.06% |
| 2000 FY | 5.13 Million USD | 956.0% |
| 1999 FY | -600 Thousand USD | 40.0% |
| 1999 Q4 | -600 Thousand USD | 25.0% |
| 1999 Q3 | -800 Thousand USD | 71.43% |
| 1999 Q1 | -300 Thousand USD | 70.0% |
| 1999 Q2 | -2.8 Million USD | -833.33% |
| 1998 Q4 | -1 Million USD | 86.11% |
| 1998 FY | -1 Million USD | 73.68% |
| 1998 Q2 | -8.2 Million USD | 9.89% |
| 1998 Q1 | -9.1 Million USD | -139.47% |
| 1998 Q3 | -7.2 Million USD | 12.2% |
| 1997 Q2 | -5.8 Million USD | 14.71% |
| 1997 Q1 | -6.8 Million USD | -172.0% |
| 1997 FY | -3.8 Million USD | -52.0% |
| 1997 Q3 | -4.8 Million USD | 17.24% |
| 1997 Q4 | -3.8 Million USD | 20.83% |
| 1996 FY | -2.5 Million USD | 0.0% |
| 1996 Q4 | -2.5 Million USD | -19.05% |
| 1996 Q3 | -2.1 Million USD | 30.0% |
| 1996 Q1 | -3.9 Million USD | 0.0% |
| 1996 Q2 | -3 Million USD | 23.08% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -433.239% |
| Alkermes plc | -166.73 Million USD | -78.899% |
| Agenus Inc. | 274.13 Million USD | 208.812% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 115.952% |
| Aptorum Group Limited | 1.35 Million USD | 22081.127% |
| Ardelyx, Inc. | 34.51 Million USD | 964.32% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 7069.486% |
| Bicycle Therapeutics plc | -481.46 Million USD | 38.045% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 924.86% |
| ChromaDex Corporation | -24.04 Million USD | -1140.411% |
| Chimerix, Inc. | -25.51 Million USD | -1069.001% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 4380.866% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1159.847% |
| CRISPR Therapeutics AG | -150.84 Million USD | -97.749% |
| Precision BioSciences, Inc. | -85.41 Million USD | -249.25% |
| Dyadic International, Inc. | -6.37 Million USD | -4576.848% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1772.177% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3991.637% |
| Lantern Pharma Inc. | -21.7 Million USD | -1274.419% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -169.859% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3391.605% |
| Incyte Corporation | -3.17 Billion USD | 90.605% |
| IO Biotech, Inc. | -140.69 Million USD | -112.009% |
| Jaguar Health, Inc. | 29.39 Million USD | 1114.916% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 5689.17% |
| Opthea Limited | 28.15 Million USD | 1159.379% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1676.723% |
| ContextLogic Inc. | -232 Million USD | -28.575% |
| MiMedx Group, Inc. | -33.9 Million USD | -779.897% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3025.885% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -12773.998% |
| NextCure, Inc. | -6.47 Million USD | -4505.435% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -490.669% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4576.187% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2552.417% |
| Vaxcyte, Inc. | -368.22 Million USD | 18.992% |
| PDS Biotechnology Corporation | -32.7 Million USD | -811.966% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1826.438% |
| Pharming Group N.V. | 109.8 Million USD | 371.66% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1614.728% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -70.23% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1510.671% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1510.671% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4101.324% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4990.341% |
| Acelyrin, Inc. | -216.9 Million USD | -37.524% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -5216.931% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -17202.436% |
| Summit Therapeutics Inc. | 34.67 Million USD | 960.281% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -4284.742% |
| Senti Biosciences, Inc. | 1.74 Million USD | 17243.333% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -61.583% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -285.139% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -4820.719% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 299084.655% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 47599.045% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -154.852% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -77.31% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 369.048% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -3826.988% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -131.031% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 4426.489% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -23.077% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1603.584% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 5.813% |
| MEI Pharma, Inc. | -3.7 Million USD | -7951.12% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2484.254% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 284.426% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1173.27% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3991.637% |
| Precigen, Inc. | -481 Thousand USD | -61915.385% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2218.415% |
| AlloVir, Inc. | -62.69 Million USD | -375.809% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -436.365% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 583.725% |
| ImmuCell Corporation | 10.99 Million USD | 2814.092% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -93.514% |
| Onconetix, Inc. | 5.33 Million USD | 5695.002% |
| PureTech Health plc | -167.19 Million USD | -78.409% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -879.297% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1460.278% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -5976.472% |
| Seer, Inc. | -4.24 Million USD | -6935.236% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1140.978% |
| Innoviva, Inc. | 255.56 Million USD | 216.72% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -433.965% |
| ESSA Pharma Inc. | -33.62 Million USD | -787.21% |
| GlycoMimetics, Inc. | -40.98 Million USD | -627.823% |
| GT Biopharma, Inc. | -1.02 Million USD | -29115.867% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -340.072% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 586.955% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -122.476% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2052.815% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -933.16% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -395861.983% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -866.541% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3540.015% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -9433.151% |
| Soligenix, Inc. | -4.95 Million USD | -5924.198% |
| Century Therapeutics, Inc. | 847 Thousand USD | 35317.71% |
| Kura Oncology, Inc. | -20.11 Million USD | -1382.722% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -628.862% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3451.965% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 16474.53% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -9230.435% |
| Autolus Therapeutics plc | -186.59 Million USD | -59.858% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -505.01% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -8.158% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 970.474% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 281.479% |
| GRI Bio, Inc. | -1.79 Million USD | -16527.313% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3220.633% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -796.936% |
| IGM Biosciences, Inc. | -72.6 Million USD | -310.839% |
| INmune Bio, Inc. | -25.41 Million USD | -1073.877% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 297.61% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -488.827% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1735.726% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -10239.745% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 884.674% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -624.278% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1035.531% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 178.924% |
| Verastem, Inc. | -37.27 Million USD | -700.188% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3187.711% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -475.169% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1870.889% |
| Histogen Inc. | -7.48 Million USD | -3884.159% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1280.555% |
| Surrozen, Inc. | -32.66 Million USD | -813.219% |
| Organovo Holdings, Inc. | -1.5 Million USD | -19693.895% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6996.345% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1673.263% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 11502.676% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 7277.43% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3459.106% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -586.649% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1946.353% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 5.838% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -41211.525% |
| Apollomics, Inc. | -27.39 Million USD | -988.863% |
| Amarin Corporation plc | -191.04 Million USD | -56.142% |
| Mesoblast Limited | 55.96 Million USD | 633.02% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1945.351% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1079.401% |
| Synaptogenix, Inc. | -28.66 Million USD | -940.748% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -31769.017% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 712.111% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -34501.3% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4005.295% |
| Exelixis, Inc. | -73.05 Million USD | -308.342% |
| Better Therapeutics, Inc. | -860 Thousand USD | -34585.349% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1142.219% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -23.583% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 40625.442% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3910.333% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 23887.4% |
| Gritstone bio, Inc. | 39.49 Million USD | 855.366% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -254.685% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -11232.756% |
| Avid Bioservices, Inc. | 169.72 Million USD | 275.748% |
| Insmed Incorporated | 721.62 Million USD | 141.337% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3163.071% |
| MediWound Ltd. | -5.32 Million USD | -5504.923% |
| OmniAb, Inc. | 9.2 Million USD | 3341.269% |
| Alector, Inc. | -35.63 Million USD | -737.035% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 446.97% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -5953.044% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2353.146% |
| Zai Lab Limited | -775 Million USD | 61.51% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 187.591% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1285.803% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -261.656% |
| Immunic, Inc. | -45.34 Million USD | -557.905% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -54.384% |
| Veracyte, Inc. | -203.82 Million USD | -46.349% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 146.733% |
| FibroGen, Inc. | 56.76 Million USD | 625.471% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3449.736% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -10451.303% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -14307.916% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 106.498% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -8828.285% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -79.734% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1769.992% |
| Galecto, Inc. | -21.21 Million USD | -1305.986% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1154.127% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 119.007% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1118.92% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2492.283% |
| XBiotech Inc. | -200.02 Million USD | -49.13% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -254.685% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 6687.765% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -745.912% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -286.301% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 5341.504% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -75.04% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -222.92% |
| Vaxxinity, Inc. | 10.13 Million USD | 3044.078% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 140.514% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2670.305% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -352.262% |
| NexImmune, Inc. | -3.13 Million USD | -9419.081% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -8539.509% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1873.96% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1000.716% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3223.22% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -239349.328% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -635.221% |
| Ainos, Inc. | 4.07 Million USD | 7414.842% |
| Pluri Inc. | 22.82 Million USD | 1406.645% |
| Prothena Corporation plc | -608.34 Million USD | 50.966% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -151.182% |
| Celularity Inc. | 65.19 Million USD | 557.576% |
| Rallybio Corporation | -24.1 Million USD | -1137.632% |
| Cue Biopharma, Inc. | -33.81 Million USD | -782.031% |
| MeiraGTx Holdings plc | -40.3 Million USD | -640.147% |
| Omeros Corporation | 331.17 Million USD | 190.071% |
| Humacyte, Inc. | -22.48 Million USD | -1226.577% |
| Immunocore Holdings plc | -358.59 Million USD | 16.816% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1113.811% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -865.322% |
| Blueprint Medicines Corporation | 702.83 Million USD | 142.441% |
| CalciMedica, Inc. | -5.53 Million USD | -5294.105% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -58.482% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2820.443% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -645.046% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -797.044% |
| Pulmatrix, Inc. | -10.41 Million USD | -2763.531% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -4890.698% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -682.062% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -167.764% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -397.621% |
| Cytokinetics, Incorporated | 642.37 Million USD | 146.436% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -5022.686% |
| Nutriband Inc. | -251.65 Thousand USD | -118431.97% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -774.275% |
| Vor Biopharma Inc. | 4.3 Million USD | 7037.07% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 95.058% |
| Evogene Ltd. | -19.63 Million USD | -1419.273% |
| ProKidney Corp. | -56.23 Million USD | -430.432% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -512.866% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3129.273% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 121.871% |
| CorMedix Inc. | -43.05 Million USD | -592.861% |
| BioLineRx Ltd. | 7.33 Million USD | 4166.167% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -986.088% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 746.4% |
| Atai Life Sciences N.V. | -28.55 Million USD | -944.52% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 13473.24% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1207.39% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1781.951% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -297.333% |
| MediciNova, Inc. | -50.78 Million USD | -487.384% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -278.522% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1325945.788% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4522.858% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -49.281% |
| Biomea Fusion, Inc. | -166.57 Million USD | -79.08% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -66.668% |
| Mereo BioPharma Group plc | -51.46 Million USD | -479.561% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -214.51% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -1.544% |
| Absci Corporation | -72.59 Million USD | -310.885% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6632.939% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -27.238% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -216.623% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -211.71% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -663.427% |
| Allakos Inc. | -24.97 Million USD | -1094.37% |
| Imunon, Inc. | -4.21 Million USD | -6978.891% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1923.43% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -120.306% |
| BioAtla, Inc. | -109.01 Million USD | -173.637% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 40625.442% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -31667.199% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2592.846% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1306.848% |
| XOMA Corporation | -29 Million USD | -928.6% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1701.292% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3208.496% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3904.484% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -139.332% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -43.298% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -264.756% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -221.566% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -34618.291% |
| Akari Therapeutics, Plc | -3.84 Million USD | -7657.971% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 18480.42% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 121.602% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -25006.07% |
| UroGen Pharma Ltd. | 4.39 Million USD | 6893.304% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 362.858% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 414615.995% |
| Orgenesis Inc. | 21.78 Million USD | 1469.326% |
| Entera Bio Ltd. | -10.62 Million USD | -2706.416% |
| GH Research PLC | -78.07 Million USD | -282.051% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1238.361% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1018.924% |
| Xencor, Inc. | 29.64 Million USD | 1106.254% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -15043.273% |
| Replimune Group, Inc. | 1.41 Million USD | 21225.637% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -121698.39% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -135.96% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -25006.07% |
| Portage Biotech Inc. | -4.98 Million USD | -5888.637% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1325945.788% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -351.127% |
| OncoCyte Corporation | -6.56 Million USD | -4445.086% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 33339.322% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -6447.791% |
| Purple Biotech Ltd. | -14.13 Million USD | -2009.874% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1155.658% |
| scPharmaceuticals Inc. | -6.54 Million USD | -4457.586% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1687.03% |
| HilleVax, Inc. | -165.48 Million USD | -80.254% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -11653.113% |
| Tharimmune, Inc. | -10.93 Million USD | -2627.795% |
| Genprex, Inc. | -6.73 Million USD | -4327.284% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 19.119% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -237.208% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -21191.506% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -8893.032% |
| OKYO Pharma Limited | -826.84 Thousand USD | -35976.038% |
| Savara Inc. | 153 Thousand USD | 195063.399% |
| Curis, Inc. | -23.88 Million USD | -1148.771% |
| Daré Bioscience, Inc. | -5.15 Million USD | -5683.233% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -38339.354% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -4704.994% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 25272.489% |
| BeiGene, Ltd. | -2.25 Billion USD | 86.761% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2517.587% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 50.955% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -60.731% |
| Erasca, Inc. | -37.21 Million USD | -701.521% |
| bluebird bio, Inc. | 108.57 Million USD | 374.746% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -23061.396% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 178.758% |
| DBV Technologies S.A. | -126.98 Million USD | -134.903% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -23061.396% |
| Moderna, Inc. | -2.9 Billion USD | 89.739% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2781.511% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2644.7% |
| Molecular Templates, Inc. | 707 Thousand USD | 42291.513% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -850.859% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 186.061% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -263.498% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -225.187% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -824.312% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -767.739% |
| MacroGenics, Inc. | -66.98 Million USD | -345.315% |
| RenovoRx, Inc. | -1.17 Million USD | -25330.009% |
| Adicet Bio, Inc. | -138.78 Million USD | -114.929% |
| Prime Medicine, Inc. | -27.94 Million USD | -967.585% |
| Aditxt, Inc. | 18.12 Million USD | 1746.134% |
| Adagene Inc. | -87.62 Million USD | -240.412% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7061.185% |
| Quantum-Si incorporated | -118.55 Million USD | -151.604% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 928.479% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3890.989% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -514.925% |
| SciSparc Ltd. | -2.06 Million USD | -14345.23% |
| Vericel Corporation | 1.27 Million USD | 23458.966% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2387.504% |
| Minerva Neurosciences, Inc. | 41 Million USD | 827.471% |
| Generation Bio Co. | 31.44 Million USD | 1048.531% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -70.1% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -864.635% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 355.842% |
| Invivyd, Inc. | -198.47 Million USD | -50.292% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -230.446% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -12340.9% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -321.379% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -4270.608% |
| 2seventy bio, Inc. | 181.71 Million USD | 264.155% |
| ADMA Biologics, Inc. | 90.06 Million USD | 431.195% |
| Clene Inc. | 3.34 Million USD | 9030.958% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3184.199% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1286.704% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4522.858% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 13.318% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1047.299% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 267.896% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -7190.459% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 6063.495% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -5626.512% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -128.922% |
| Evaxion Biotech A/S | 5.28 Million USD | 5742.194% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -164.99% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -127.232% |
| Trevena, Inc. | 2.25 Million USD | 13310.54% |
| Surrozen, Inc. | -32.66 Million USD | -813.219% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -479.099% |
| Cingulate Inc. | 3.08 Million USD | 9776.441% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -10056.418% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 4250.466% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3110.491% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -276.05% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -126.922% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -182.631% |
| Clearmind Medicine Inc. | -3.94 Million USD | -7465.85% |
| Kronos Bio, Inc. | -36.05 Million USD | -727.353% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3270.305% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 20557.34% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -449.79% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2169.129% |
| ImmunityBio, Inc. | 618.22 Million USD | 148.25% |
| Korro Bio, Inc. | -132.94 Million USD | -124.377% |
| Kineta, Inc. | -4.54 Million USD | -6468.906% |
| BioVie Inc. | -17.73 Million USD | -1582.202% |
| Codexis, Inc. | -43.27 Million USD | -589.362% |
| Celularity Inc. | 65.19 Million USD | 557.576% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -9312.875% |
| Celcuity Inc. | 6.78 Million USD | 4497.341% |
| Virax Biolabs Group Limited | -3.36 Million USD | -8764.754% |
| Cibus, Inc. | -8.07 Million USD | -3592.671% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -6953.535% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 6627.221% |
| IN8bio, Inc. | -16.38 Million USD | -1720.087% |
| Kodiak Sciences Inc. | -103.87 Million USD | -187.166% |
| Annexon, Inc. | -193.75 Million USD | -53.954% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 828694.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1604.635% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -8391.147% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 128.294% |
| Eyenovia, Inc. | 1.25 Million USD | 23798.54% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1208.694% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9098.088% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -797.206% |
| Arcellx, Inc. | -296.95 Million USD | -0.45% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1429.242% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -406.656% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1339.157% |
| Moolec Science SA | 117.61 Thousand USD | 253716.855% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -676.828% |
| Geron Corporation | 14.76 Million USD | 2120.825% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -686.682% |
| Royalty Pharma plc | 5.65 Billion USD | 105.272% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -110.926% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -4167.791% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -5462.22% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -111.96% |
| Humacyte, Inc. | -22.48 Million USD | -1226.577% |
| Structure Therapeutics Inc. | -124.33 Million USD | -139.904% |
| 89bio, Inc. | -289.05 Million USD | -3.197% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1081.737% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -16629.893% |
| Genelux Corporation | -6.89 Million USD | -4223.728% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -860.411% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 456.815% |
| Notable Labs, Ltd. | -9.77 Million USD | -2951.289% |
| Liquidia Corporation | -80.17 Million USD | -272.049% |
| Mustang Bio, Inc. | -3.73 Million USD | -7884.315% |
| Immunovant, Inc. | -635.22 Million USD | 53.041% |
| Quantum-Si incorporated | -118.55 Million USD | -151.604% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1598.326% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -7099.952% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3816.133% |
| Acasti Pharma Inc. | -23 Million USD | -1196.649% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -8758.738% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1735.726% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -116.563% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -9471.866% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1241.733% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1506.409% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -76.215% |
| PepGen Inc. | -60.67 Million USD | -391.666% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1198.285% |
| United Therapeutics Corporation | -507.7 Million USD | 41.246% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1459.626% |
| Solid Biosciences Inc. | -47.75 Million USD | -524.699% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -34501.3% |
| Immuneering Corporation | -54.94 Million USD | -442.917% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6996.345% |
| Silo Pharma, Inc. | -3.52 Million USD | -8363.903% |
| Belite Bio, Inc | -87.27 Million USD | -241.802% |
| XOMA Corporation | -29 Million USD | -928.6% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -321.933% |
| Bionomics Limited | 227 Million USD | 231.401% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -156.526% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -11676.313% |
| uniQure N.V. | -102.95 Million USD | -189.744% |
| Cassava Sciences, Inc. | -121.13 Million USD | -146.247% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7061.185% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 828.417% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2393.888% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -9540.424% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 281509.434% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9098.088% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3449.736% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3922.303% |
| Altimmune, Inc. | -134.48 Million USD | -121.801% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 250.604% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -11676.313% |
| Compugen Ltd. | -12.9 Million USD | -2211.64% |
| Peak Bio, Inc. | 10.34 Million USD | 2984.811% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -105304.24% |
| Benitec Biopharma Inc. | -50.58 Million USD | -489.724% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -185.892% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1618.422% |
| Zura Bio Limited | -99.8 Million USD | -198.874% |
| PolyPid Ltd. | 6.17 Million USD | 4934.587% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 502.447% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1618.422% |
| Instil Bio, Inc. | 75.35 Million USD | 495.836% |
| argenx SE | -2.02 Billion USD | 85.297% |
| Immunome, Inc. | -97.02 Million USD | -207.428% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1226.046% |
| Verona Pharma plc | -220.44 Million USD | -35.316% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -315.781% |
| Shattuck Labs, Inc. | -121.42 Million USD | -145.663% |
| CervoMed Inc. | -7.79 Million USD | -3727.793% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -60.806% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -6721.267% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -126.426% |
| Moolec Science SA | 117.61 Thousand USD | 253716.855% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -12937.456% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1976.254% |
| AnaptysBio, Inc. | -18.15 Million USD | -1543.403% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1543.493% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -323.827% |
| NeurAxis, Inc. | 145.7 Thousand USD | 204831.64% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2755.751% |
| Lumos Pharma, Inc. | -28.49 Million USD | -946.903% |
| Achilles Therapeutics plc | -126.92 Million USD | -135.018% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -315.781% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -45390.37% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1335.913% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 20557.34% |
| Nutriband Inc. | -251.65 Thousand USD | -118431.97% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2164.779% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3909.328% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 187.683% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1356.768% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 33.338% |
| Palisade Bio, Inc. | -12.06 Million USD | -2372.801% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -112.595% |
| Beam Therapeutics Inc. | -262.72 Million USD | -13.54% |
| Neurogene Inc. | -131.95 Million USD | -126.057% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1467.318% |
| AEON Biopharma, Inc. | -4.88 Million USD | -6012.582% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 20.917% |
| Sesen Bio, Inc. | -112.55 Million USD | -165.025% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -198.712% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -12605.294% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -664.347% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -258.173% |
| Athira Pharma, Inc. | -88.99 Million USD | -235.166% |
| Vaccinex, Inc. | -1.28 Million USD | -23059.472% |
| HCW Biologics Inc. | 2.85 Million USD | 10541.996% |
| XOMA Corporation | -29 Million USD | -928.6% |
| Nektar Therapeutics | 210.24 Million USD | 241.883% |
| Arvinas, Inc. | -313.8 Million USD | 4.941% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 18480.42% |
| Merus N.V. | -192.88 Million USD | -54.649% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 597.281% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -4199.423% |
| Rezolute, Inc. | -68.16 Million USD | -337.587% |
| Clene Inc. | 3.34 Million USD | 9030.958% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2162.031% |
| BeyondSpring Inc. | -13.75 Million USD | -2068.622% |
| Synlogic, Inc. | -6.68 Million USD | -4362.139% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 26404.586% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3428.019% |
| Peak Bio, Inc. | 10.34 Million USD | 2984.811% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -261.919% |
| Krystal Biotech, Inc. | -350.23 Million USD | 14.83% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 340.317% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -76.51% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -9348.223% |
| MannKind Corporation | 143.89 Million USD | 307.294% |
| Ikena Oncology, Inc. | -109.15 Million USD | -173.273% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3839.955% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -801.19% |
| Gossamer Bio, Inc. | 180.35 Million USD | 265.393% |
| CohBar, Inc. | -5.93 Million USD | -4929.633% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -902.736% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6632.939% |
| Legend Biotech Corporation | -949.39 Million USD | 68.581% |
| Mural Oncology plc | -255.84 Million USD | -16.593% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1025.948% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -6232.343% |
| Disc Medicine, Inc. | -358.28 Million USD | 16.743% |
| Champions Oncology, Inc. | 4.81 Million USD | 6298.961% |
| REGENXBIO Inc. | 54.76 Million USD | 644.65% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -110828.314% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -97.514% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3209.962% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -269.711% |
| Vaxart, Inc. | -8.24 Million USD | -3519.634% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -494.448% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -134.571% |
| Cellectis S.A. | -43.85 Million USD | -580.182% |
| Longeveron Inc. | -2.9 Million USD | -10157.703% |
| Repare Therapeutics Inc. | -107.85 Million USD | -176.562% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 130.803% |
| Inozyme Pharma, Inc. | 12 Million USD | 2584.955% |
| Revolution Medicines, Inc. | -608.2 Million USD | 50.955% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -24151.545% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -12.514% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -98.767% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1806.397% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -40210.0% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.881% |
| Denali Therapeutics Inc. | -74.86 Million USD | -298.443% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2387.504% |
| Veru Inc. | 4.77 Million USD | 6340.501% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2552.445% |
| Cingulate Inc. | 3.08 Million USD | 9776.441% |
| Passage Bio, Inc. | 4.58 Million USD | 6605.867% |
| Context Therapeutics Inc. | -14.44 Million USD | -1964.343% |
| Exicure, Inc. | 5.84 Million USD | 5199.915% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -29.481% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -653.839% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2001.052% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -407.122% |
| Nuvalent, Inc. | -335.38 Million USD | 11.06% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 17299.271% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -300.491% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3255.388% |
| OmniAb, Inc. | 9.2 Million USD | 3341.269% |
| Anew Medical, Inc. | 1.43 Million USD | 20923.825% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1920.892% |
| Lipocine Inc. | -4.75 Million USD | -6173.809% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -171.601% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2058.466% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -488.827% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1298.353% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -4338.238% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -353.148% |
| Ocugen, Inc. | -32.52 Million USD | -817.235% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -248.576% |
| Q32 Bio Inc. | -37.94 Million USD | -686.06% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -47399.045% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2104.849% |
| Equillium, Inc. | -22.39 Million USD | -1232.145% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1066.669% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -814.262% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -120221.078% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 322.538% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 9427.517% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 90921.182% |
| Dominari Holdings Inc. | 195 Thousand USD | 153071.282% |
| Edesa Biotech, Inc. | -5.26 Million USD | -5563.548% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3245.228% |
| Bio-Techne Corporation | 267.74 Million USD | 211.409% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1740.299% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -152.59% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3449.851% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2257.869% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -21.694% |
| Nkarta, Inc. | 57.29 Million USD | 620.592% |
| BioCardia, Inc. | 212 Thousand USD | 140804.717% |
| Iterum Therapeutics plc | 13.43 Million USD | 2319.78% |